NCT00910780View on ClinicalTrials.gov

Metabolic Effects of Antipsychotic Substitution in Children

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Diabetes
Interventions
DRUG

Aripiprazole

via oral tablets, everyday

DRUG

Zyprexa

via oral tablets, taken once daily

DRUG

Risperdal

via oral tablets, taken once daily

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00910780 - Metabolic Effects of Antipsychotic Substitution in Children | Biotech Hunter | Biotech Hunter